James Bircher
Chief Operating Officer at FREELINE THERAPEUTICS HOLDINGS PLC
Network origin in James Bircher first degree
Entity | Entity type | Industry | |
---|---|---|---|
Subsidiary | Biotechnology | 24 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to James Bircher via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder Chief Executive Officer Director/Board Member Founder Director/Board Member Human Resources Officer | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Administrative Officer | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
Georgetown University | College/University | Undergraduate Degree Undergraduate Degree | |
LEXICON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member | |
Novalgen Ltd.
Novalgen Ltd. BiotechnologyHealth Technology Part of Convergys Capital Ltd., Novalgen Ltd. is a clinical stage immunology company based in Northwood Hills, UK. Novalgen is developing breakthrough immunotherapies for people with immunologically driven diseases using their autoregulation platform. The British company's lead program, NVG-111, is an ROR1-targeting bispecific antibody T-cell engager for the treatment of both hematological malignancies and solid tumors using their breakthrough bispecific antibody technology. The company's lead AR program, NVG-222, builds on the success of NVG-111 and is primed for entry into the clinic in 2024. The company was founded by Amit Chunilal Nathwani and has been the CEO since incorporation. | Biotechnology | Founder | |
Royal Free Hospital Medical School | College/University | Corporate Officer/Principal | |
University College London | College/University | Corporate Officer/Principal | |
University of Aberdeen | College/University | Undergraduate Degree | |
The Open University | College/University | Doctorate Degree | |
Akin, Gump, Strauss, Hauer & Feld LLP
Akin, Gump, Strauss, Hauer & Feld LLP Miscellaneous Commercial ServicesCommercial Services Akin Gump Strauss Hauer & Feld LLP provides legal services. The firm's areas of practice includes appellate, litigation, business and commercial litigation, dispute resolution, government contracts, internal investigations, labor and employment, oil and gas patent, trademark and copyright infringement, product liability and toxic tort securities litigation. The company was founded in 1971 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The District of Columbia Bar
The District of Columbia Bar Miscellaneous Commercial ServicesCommercial Services The District of Columbia Bar provides legal services. The private company is based in Washington. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Georgetown University Law Center | College/University | Graduate Degree | |
PURETECH HEALTH PLC | Biotechnology | Chief Tech/Sci/R&D Officer | |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal | |
University of Salford | College/University | Undergraduate Degree | |
AQUESTIVE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
STRYKER CORPORATION | Medical Specialties | Corporate Officer/Principal | |
The Warren Alpert Medical School | College/University | Doctorate Degree | |
Brown University | College/University | Undergraduate Degree | |
AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Adicet Therapeutics, Inc.
Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Pharmaceuticals: Major | Director/Board Member | |
PRAXIS PRECISION MEDICINES, INC. | Pharmaceuticals: Major | Director/Board Member | |
ADICET BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
SCHRÖDINGER, INC. | Packaged Software | Director/Board Member | |
ORCHARD THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Human Resources Officer | |
New Context Ltd. | Director/Board Member | ||
University of the Witwatersrand | College/University | Doctorate Degree | |
Meredith College | College/University | Masters Business Admin | |
Boston College | College/University | Undergraduate Degree | |
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Exo Therapeutics, Inc.
Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director of Finance/CFO | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Technical University of Denmark | College/University | Masters Business Admin | |
University of Copenhagen | College/University | Graduate Degree | |
Auregen Biotherapeutics SA
Auregen Biotherapeutics SA Packaged SoftwareTechnology Services Auregen Biotherapeutics SA develops three dimensional (3D) bioprinting technology for patients with rare disorders. The company is headquartered in Geneva, Switzerland. | Packaged Software | Chief Tech/Sci/R&D Officer | |
AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Auregen Biotherapeutics, Inc.
Auregen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Auregen Biotherapeutics, Inc. provides biotechnology services. The CEO of the American company is Richard John Davies. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Georgetown University School of Medicine | College/University | Doctorate Degree | |
TAYSHA GENE THERAPIES, INC. | Biotechnology | Director/Board Member | |
George Mason University | College/University | Doctorate Degree | |
KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistics
International
United States | 35 |
United Kingdom | 12 |
Denmark | 4 |
South Africa | 2 |
Switzerland | 2 |
Sectoral
Health Technology | 27 |
Consumer Services | 17 |
Commercial Services | 5 |
Technology Services | 3 |
Finance | 2 |
Operational
Director/Board Member | 54 |
Corporate Officer/Principal | 37 |
Independent Dir/Board Member | 22 |
Chief Tech/Sci/R&D Officer | 21 |
Undergraduate Degree | 14 |
Most connected contacts
Insiders | |
---|---|
Julia Gregory | 22 |
Chris Hollowood | 19 |
Theresa Heggie | 16 |
Jeffrey Chodakewitz | 15 |
Julie Krop | 12 |
Colin Love | 11 |
Michael Parini | 8 |
Eric Fink | 8 |
Amit Chunilal Nathwani | 7 |
Martin Andrews | 7 |
Pamela Foulds | 6 |
Alison Long | 5 |
Stephen P. Diamond | 5 |
Romuald Corbau | 4 |
Henning R. Stennicke | 4 |
- Stock Market
- Insiders
- James Bircher
- Company connections